Search

Search Constraints

You searched for: Author/Creator Chuma, Makoto

Search Results

1. Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis. Issue 2 (5th January 2021)

2. Anti‐adipogenic and antiviral effects of l‐carnitine on hepatitis C virus infection. Issue 5 (3rd October 2016)

3. Characteristics and Prognosis of De Novo Hepatocellular Carcinoma After Sustained Virologic Response. Issue 7 (5th May 2021)

4. Circulating microRNA‐1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma. Issue 7 (23rd May 2019)

5. Clinical outcomes of antithrombin III‐based therapy for patients with portal vein thrombosis: A retrospective, multicenter study. Issue 1 (4th October 2022)

6. Comparative study between sorafenib and lenvatinib as the first‐line therapy in the sequential treatment of unresectable hepatocellular carcinoma in a real‐world setting. Issue 1 (17th December 2021)

8. Fib-4 index predicts prognosis after achievement of sustained virologic response following direct-acting antiviral treatment in patients with hepatitis C virus infection. Issue 2 (29th November 2022)

9. Intraprocedurally EOB-MRI/US fusion imaging focusing on hepatobiliary phase findings can help to reduce the recurrence of hepatocellular carcinoma after radiofrequency ablation. (1st January 2020)

10. Liver stiffness does not affect ultrasound‐guided attenuation coefficient measurement in the evaluation of hepatic steatosis. Issue 2 (29th December 2019)